Valuation: Olympus Corporation

Market Cap 2,265B 14.29B 12.26B 11.45B 10.5B 19.75B 1,366B 20.08B 135B 52.9B 685B 53.67B 52.5B P/E 2027 *
22.1x
P/E 2028 * 18.8x
Enterprise Value 2,347B 14.81B 12.7B 11.86B 10.88B 20.46B 1,415B 20.8B 140B 54.81B 710B 55.6B 54.39B EV / Sales 2027 *
2.18x
EV / Sales 2028 * 2.1x
Free-Float
94.58%
Yield 2027 *
1.45%
Yield 2028 * 1.51%
1 day+2.88%
1 week+3.82%
Current month+19.33%
1 month+24.02%
3 months+15.57%
6 months+37.87%
Current year+7.18%
1 week 12.91
Extreme 12.91
13.64
1 month 10.38
Extreme 10.38
13.64
Current year 8.08
Extreme 8.08
13.64
1 year 8.08
Extreme 8.08
13.73
3 years 8.08
Extreme 8.08
19.69
5 years 8.08
Extreme 8.08
74.99
10 years 6.26
Extreme 6.2625
74.99
Manager TitleAgeSince
Chief Executive Officer 63 2025-05-31
Director of Finance/CFO 59 2026-03-31
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Chairman 69 2023-03-31
Director/Board Member 41 2019-05-31
Director/Board Member 63 2019-05-31
Change 5-day change 1-year change 3-year change Capi.($)
+2.88%+3.82% - - 14.09B
+4.36%+1.59%+22.95%+15.10% 218B
+6.20%+2.90%-0.21%-15.36% 140B
+1.68%-0.29%-16.50%+39.58% 138B
+3.08%+1.64%-49.62%+3.66% 73.14B
+1.43%-0.57%+17.21%+21.20% 52.44B
+1.32%+2.43%-16.15%-12.09% 50.85B
+5.02%+5.19%+29.82%+31.19% 41.92B
+3.88%+0.13%+39.96%+55.96% 39.42B
+2.75%+3.11%+0.76%+8.06% 32.81B
Average +3.24%-1.97%+3.13%+16.37% 87.43B
Weighted average by Cap. +3.62%-2.40%+2.53%+14.16%

Financials

2027 *2028 *
Net sales 1,078B 6.8B 5.83B 5.45B 5B 9.4B 650B 9.55B 64.27B 25.17B 326B 25.53B 24.98B 1,115B 7.04B 6.04B 5.64B 5.17B 9.73B 673B 9.89B 66.51B 26.04B 337B 26.42B 25.85B
Net income 102B 643M 551M 515M 472M 888M 61.42B 903M 6.07B 2.38B 30.8B 2.41B 2.36B 121B 764M 655M 612M 561M 1.06B 73B 1.07B 7.22B 2.83B 36.61B 2.87B 2.81B
Net Debt 81.71B 516M 442M 413M 379M 712M 49.28B 724M 4.87B 1.91B 24.71B 1.94B 1.89B 77.99B 492M 422M 394M 362M 680M 47.03B 691M 4.65B 1.82B 23.59B 1.85B 1.81B
Logo Olympus Corporation
Olympus Corp is a Japan-based company mainly engaged in the manufacture and sale of endoscopes, therapeutic equipment, scientific and other products. The Company operates through three business segments. The Endoscope segment provides gastrointestinal endoscopes, surgical endoscopes, and medical services. The Therapeutic Equipment segment provides gastrointestinal treatment instruments, urology products, respiratory products, energy devices, otolaryngology products and gynecology products. The Others segment provides biomaterials and orthopedic instruments. The Company is also engaged in the business activities, including holding companies and financial investments related to each business.
Employees
28,138
Date Price Change Volume
26-08-19 US$13.58 +2.88% 29,144
26-08-18 US$13.20 +1.93% 75,314
26-08-17 US$12.95 -1.52% 18,903
26-08-14 US$13.15 +1.54% 26,117
26-08-13 US$12.95 -0.99% 59,857
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
14
Last Close Price
2,131.50JPY
Average target price
2,034.62JPY
Spread / Average Target
-4.55%

Quarterly revenue - Rate of surprise